Skip to main content
Public offering pulls in $79.3M for Accelerate Diagnostics

A public offering of 2.75 million shares of common stock has brought in $79.3 million in gross proceeds for Accelerate Diagnostics. Net proceeds from the offering, which included a 30-day option for underwriters to buy up to 412,500 additional shares, will be used to support commercialization efforts and general corporate functions.

Full Story: